Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Tango Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 115 | 1 | 141 | +27 |
| Shares | 127.2M | 10.0K | 140.0M | +12.7M (+10.0%) |
| Value | $651.7M | $51.2K | $1.18B | +$524.1M (+80.4%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (37)
Institutions that held Tango Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (10)
Institutions that held Tango Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 218,779 | $1.12M |
| Samsara BioCapital, LLC | 210,000 | $1.08M |
| Acadian Asset Management LLC | 81,953 | $419.0K |
| Polar Asset Management Partners Inc. | 56,100 | $287.2K |
| XTX Topco Ltd | 55,806 | $285.7K |
| Citadel Advisors LLC | 55,065 | $281.9K |
| Simplex Trading, LLC | 49,901 | $255.0K |
| Allostery Investments LP | 40,000 | $204.8K |
| Group One Trading, L.P. | 1,400 | $7.17K |
| Twin Peaks Wealth Advisors, LLC | 1 | $7 |
Not filed for Q3 2025 yet (1)
Institutions that held Tango Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Northeast Financial Consultants Inc | 10,000 | $51.2K |